Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selective vs Conventional Anticoagulation in Asian Arthroplasty
NCT03804697Completed
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Aug 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of rivaroxaban in deep vein thrombosis (DVT), sponsored by Guangdong Provincial People's Hospital. Primary endpoint: The Incidence of Deep Vein Thrombosis at 6 months. Started Aug 2016; status: completed.
02
Drugs
rivaroxaban
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT03804697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03804697.